+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05940623

Evaluating Home Intraocular Pressure Telemonitoring Versus Standard Care with Smartphone Support for Management of Primary Open-Angle Glaucoma

Led by The University of Hong Kong · Updated on 2026-09-03

142

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the impact of home intra-ocular pressure IOP telemonitoring combined with smartphone-based intervention versus smartphone-based intervention alone in patients with newly diagnosed primary open-angle glaucoma POAG. This 30-month prospective, randomized clinical trial aims to compare IOP levels measured by Goldmann applanation tonometry GAT and rates of retinal nerve fiber layer RNFL thinning between these two management approaches. The study seeks to determine if home telemonitoring allows more precise IOP assessment to guide therapy and slow disease progression. Participants are randomly assigned to one of two management paradigms. Management Paradigm I involves using the iCare HOME rebound tonometer to self-measure IOP at home, with at least six measurements per week uploaded to a secure cloud system. Investigators review these data monthly to adjust treatment following a defined algorithm. Management Paradigm II includes standard care with topical prostaglandin analogue treatment guided by clinic-measured IOP and the same smartphone-based intervention without home telemonitoring. Both groups receive smartphone messages every 4 weeks about IOP control and medication adherence. During the 30-month study, participants attend clinic visits every 3 months for GAT IOP measurements, optical coherence tomography OCT imaging of the RNFL, and visual field testing. Researchers monitor changes in IOP, RNFL and ganglion cell inner plexiform layer thicknesses, and visual field progression. Safety is assessed by tracking adverse changes such as visual acuity loss or IOP spikes. Participants continue home IOP monitoring if assigned to Management Paradigm I until study completion, with ongoing adherence and treatment adjustments monitored via smartphone communication.

CONDITIONS

Brief Title

Impact of Home Intraocular Pressure Telemonitoring on Intraocular Pressure Control and Glaucoma Progression

Research Team

C

Christopher Leung

A

Anita Yau

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here